Cargando…

Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors

PURPOSE: It is important to monitor disease-specific health-related quality of life (HRQoL) in breast cancer (BC) survivors to identify potential unmet supportive care needs. However, previous studies were characterized by small samples of mostly short-term survivors and were limited to certain age...

Descripción completa

Detalles Bibliográficos
Autores principales: Doege, Daniela, Thong, Melissa S. Y., Koch-Gallenkamp, Lena, Bertram, Heike, Eberle, Andrea, Holleczek, Bernd, Nennecke, Alice, Pritzkuleit, Ron, Waldmann, Annika, Zeissig, Sylke R., Brenner, Hermann, Arndt, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587098/
https://www.ncbi.nlm.nih.gov/pubmed/35879433
http://dx.doi.org/10.1007/s00432-022-04204-w
_version_ 1784813835666849792
author Doege, Daniela
Thong, Melissa S. Y.
Koch-Gallenkamp, Lena
Bertram, Heike
Eberle, Andrea
Holleczek, Bernd
Nennecke, Alice
Pritzkuleit, Ron
Waldmann, Annika
Zeissig, Sylke R.
Brenner, Hermann
Arndt, Volker
author_facet Doege, Daniela
Thong, Melissa S. Y.
Koch-Gallenkamp, Lena
Bertram, Heike
Eberle, Andrea
Holleczek, Bernd
Nennecke, Alice
Pritzkuleit, Ron
Waldmann, Annika
Zeissig, Sylke R.
Brenner, Hermann
Arndt, Volker
author_sort Doege, Daniela
collection PubMed
description PURPOSE: It is important to monitor disease-specific health-related quality of life (HRQoL) in breast cancer (BC) survivors to identify potential unmet supportive care needs. However, previous studies were characterized by small samples of mostly short-term survivors and were limited to certain age ranges, stages and/or treatments. METHODS: We used data from 3045 long-term BC survivors (5–15 years post-diagnosis) recruited in a German multi-regional population-based study. We assessed disease-specific HRQoL with the EORTC QLQ-BR23, scoring from 0 to 100. Differences in functioning and symptoms according to age at survey, self-reported treatments, stage, and disease status (disease-free vs. active disease) were assessed with multiple regression. Active disease was defined as any self-report of recurrence, metastasis or second primary cancer after the index cancer. RESULTS: Older BC survivors reported a higher body image and a better future perspective, but lower sexual functioning. Survivors aged 30–49 years who had breast-conserving therapy or mastectomy with breast reconstruction reported a better body image compared to those who had mastectomy only. We also found differences in symptoms according to treatments in some age groups. Stage at diagnosis was not associated with HRQoL overall and in most age subgroups. Disease-free BC survivors aged 30–79 years reported a better future perspective and less systemic therapy side effects than those with active disease. CONCLUSION: Several treatment-associated symptoms and functioning detriments were found 5–15 years after diagnosis. The results emphasize the need of a comprehensive, individualized survivorship care, recognizing differential needs of long-term BC survivors according to age, treatment modalities, and disease status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04204-w.
format Online
Article
Text
id pubmed-9587098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95870982022-10-23 Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors Doege, Daniela Thong, Melissa S. Y. Koch-Gallenkamp, Lena Bertram, Heike Eberle, Andrea Holleczek, Bernd Nennecke, Alice Pritzkuleit, Ron Waldmann, Annika Zeissig, Sylke R. Brenner, Hermann Arndt, Volker J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: It is important to monitor disease-specific health-related quality of life (HRQoL) in breast cancer (BC) survivors to identify potential unmet supportive care needs. However, previous studies were characterized by small samples of mostly short-term survivors and were limited to certain age ranges, stages and/or treatments. METHODS: We used data from 3045 long-term BC survivors (5–15 years post-diagnosis) recruited in a German multi-regional population-based study. We assessed disease-specific HRQoL with the EORTC QLQ-BR23, scoring from 0 to 100. Differences in functioning and symptoms according to age at survey, self-reported treatments, stage, and disease status (disease-free vs. active disease) were assessed with multiple regression. Active disease was defined as any self-report of recurrence, metastasis or second primary cancer after the index cancer. RESULTS: Older BC survivors reported a higher body image and a better future perspective, but lower sexual functioning. Survivors aged 30–49 years who had breast-conserving therapy or mastectomy with breast reconstruction reported a better body image compared to those who had mastectomy only. We also found differences in symptoms according to treatments in some age groups. Stage at diagnosis was not associated with HRQoL overall and in most age subgroups. Disease-free BC survivors aged 30–79 years reported a better future perspective and less systemic therapy side effects than those with active disease. CONCLUSION: Several treatment-associated symptoms and functioning detriments were found 5–15 years after diagnosis. The results emphasize the need of a comprehensive, individualized survivorship care, recognizing differential needs of long-term BC survivors according to age, treatment modalities, and disease status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04204-w. Springer Berlin Heidelberg 2022-07-25 2022 /pmc/articles/PMC9587098/ /pubmed/35879433 http://dx.doi.org/10.1007/s00432-022-04204-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article – Cancer Research
Doege, Daniela
Thong, Melissa S. Y.
Koch-Gallenkamp, Lena
Bertram, Heike
Eberle, Andrea
Holleczek, Bernd
Nennecke, Alice
Pritzkuleit, Ron
Waldmann, Annika
Zeissig, Sylke R.
Brenner, Hermann
Arndt, Volker
Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
title Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
title_full Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
title_fullStr Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
title_full_unstemmed Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
title_short Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
title_sort clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
topic Original Article – Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587098/
https://www.ncbi.nlm.nih.gov/pubmed/35879433
http://dx.doi.org/10.1007/s00432-022-04204-w
work_keys_str_mv AT doegedaniela clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT thongmelissasy clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT kochgallenkamplena clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT bertramheike clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT eberleandrea clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT holleczekbernd clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT nenneckealice clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT pritzkuleitron clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT waldmannannika clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT zeissigsylker clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT brennerhermann clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors
AT arndtvolker clinicalandsociodemographicdeterminantsofdiseasespecifichealthrelatedqualityoflifeinlongtermbreastcancersurvivors